There are many factors that impede CD8+ T-cell infiltration and activation during tumour progression, such as reduced tumour perfusion [45], blocked antigen presentation [40], high-potassium environment [46] and high expression of inhibitory receptors [47]. The gene discussed is CD8A; the disease is neoplasm.